Whether you are designing employee health benefits, building an international treatment network, referring patients overseas, or exploring China’s AI medical ecosystem — China Care provides a transparent, compliant framework and a single named contact you can reach directly.
Each partnership track is designed for a specific type of organisation. Click through to the relevant tab below for full details.
Multinationals and mid-market employers with staff in Asia, the Middle East, or Africa who want to offer China-based health screening or treatment access as part of a benefits package.
International health insurers and third-party administrators seeking to add Chinese hospitals to their treatment network. We provide pre-authorisation support and full clinical documentation.
Oncologists, GPs, patient advocates, and medical tourism agencies who want a reliable, transparent China referral partner. Fixed referral fee per admitted patient, paid by China Care.
Overseas healthcare companies, hospital groups, and investors who want to evaluate or partner with Chinese AI medical technology firms — AI radiology, pathology analysis, smart hospital platforms.
Offer your employees access to executive health screening, cancer treatment, dental care, and elective procedures in China as part of your benefits package. Particularly suited to companies with staff in Asia, the Middle East, and Africa who want international-quality care at a cost that makes it genuinely viable.
Indicative. Actual costs depend on package, hospital, and employee health status.
Add China’s leading hospitals to your international treatment network. China Care acts as the in-country coordinator, handling clinical logistics so your policyholders receive seamless, documented access to treatment — with full English records for claims processing.
Payment is made directly to the hospital. China Care does not process or hold insurance funds.
For oncologists, GPs, medical tourism agencies, and patient advocates who want a reliable, transparent China referral partner. We handle everything after you refer — hospital matching, logistics, interpretation, and follow-up — while you retain the patient relationship.
Referral fees are paid by China Care — never charged to the patient or deducted from treatment costs. Exact figures confirmed in the referral agreement.
China leads globally in AI-assisted medical imaging, pathology analysis, genomic diagnostics, and smart hospital infrastructure. The sector is moving fast, is largely Chinese-language, and is difficult to navigate remotely.
Overseas healthcare companies, hospital groups, PE funds, and med-tech investors engage China Care as a navigation and introduction service. We identify the right companies for your specific interest area, make warm introductions in Chinese, and facilitate initial meetings — removing the friction of cold outreach and language barriers.
China Care coordinates a defined set of medical services and business introductions where China holds a genuine clinical, cost, or strategic advantage. We do not position ourselves as a general medical tourism directory.
All treatment costs are quoted directly by the hospital. We publish our coordination fees. Partners receive full cost transparency before any patient is referred.
Request a Partnership BriefSelect a treatment type and origin country to see an indicative cost comparison. Use this as a starting point when discussing a partnership with your team or clients.
All figures are indicative 2026 ranges. Actual costs are quoted directly by the hospital.
Representative 2026 ranges. Use these when designing benefit packages, setting coverage limits, or briefing your board on the cost case for China.
| Treatment | USA | UK / Germany | Singapore | China |
|---|---|---|---|---|
| CAR-T Cell Therapy | USD 400,000–500,000 | €200,000–300,000 | Not available | USD 60,000–120,000 |
| Cancer Surgery (major) | USD 80,000–150,000 | £40,000–80,000 | USD 35,000–70,000 | USD 15,000–40,000 |
| Proton Therapy (full course) | USD 100,000–180,000 | £80,000–120,000 | USD 60,000–90,000 | USD 25,000–50,000 |
| Stem Cell Therapy (MSC) | Not commercially available | Not commercially available | Not commercially available | USD 15,000–40,000 |
| Executive Health Screening (2 days) | USD 3,000–8,000 | £2,000–5,000 | USD 2,000–4,000 | USD 800–2,500 |
| Dental Implant (single, all-inclusive) | USD 4,000–6,000 | £2,500–4,500 | USD 2,500–4,000 | USD 800–1,500 |
All figures are indicative ranges for 2026. Actual costs vary by hospital, case complexity, and treatment duration. Treatment costs are quoted directly by the hospital and are never marked up by China Care.
The onboarding process is the same across all four tracks. What differs is the fee structure and the ongoing relationship model.
Every element of how China Care operates — legally, financially, and clinically — is designed to give institutional partners the documentation and accountability they need.
Questions we receive consistently from HR teams, insurers, referring clinicians, and companies exploring China’s AI healthcare sector.
Fill in the form below or reach out directly. Every enquiry is handled personally by Xiaoyue Peng — no sales team, no automated responses.
China Care is a lean, founder-run operation. Every partner enquiry is handled by Xiaoyue Peng personally.